Cansortium (CNTMF) Price & Analysis

Q: What was Cansortium’s price range in the past 12 months?

Cansortium lowest stock price was $0.04 and its highest was $0.10 in the past 12 months.

Q: When is Cansortium’s upcoming earnings report date?

Cansortium’s upcoming earnings report date is May 04, 2026 which is in 128 days.

Q: How were Cansortium’s earnings last quarter?

Cansortium released its earnings results on Nov 28, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.

Q: Is Cansortium overvalued?

According to Wall Street analysts Cansortium’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Cansortium pay dividends?

Cansortium does not currently pay dividends.

Q: What is Cansortium’s EPS estimate?

Cansortium’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Cansortium have?

Cansortium has 612,839,970 shares outstanding.

Q: What happened to Cansortium’s price movement after its last earnings report?

Cansortium reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.

Q: Which hedge fund is a major shareholder of Cansortium?

Currently, no hedge funds are holding shares in CNTMF

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Compare

76 Followers

CNTMF Stock Chart & Stats

$0.04

<$0.01(0.57%)

At close: Jan 08 4:00 PM EST

$0.04

<$0.01(0.57%)

Day’s Range― - ―

52-Week Range$0.04 - $0.10

Previous CloseN/A

Volume189.91K

Average Volume (3M)298.25K

Market Cap

N/A

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.44

Next Earnings

May 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding612,839,970

10 Day Avg. Volume366,269

30 Day Avg. Volume298,254

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Cansortium News

Fluent reports Q3 EPS (2c) vs. (4c) last year

Reports Q3 revenue $26M vs. $26.1M last year. “During the third quarter, we continued to execute on our...

29d ago

FLUENT Hails U.S. Cannabis Rescheduling as Catalyst for Growth and Market Rationalization

Cansortium ( ($TSE:FNT.U) ) just unveiled an announcement. FLUENT Corp. has welcomed the U.S. federal decision to reschedule...

9d ago

FLUENT Corp. Focuses on Margin Expansion and Operational Efficiency in Q3 2025 Results

Cansortium ( ($TSE:FNT.U) ) has shared an announcement. FLUENT Corp. reported its third-quarter 2025 financial results, highlighting efforts...

29d ago

FLUENT Cannabis announces opening of new dispensary in Brandon, Florida

FLUENT announced that its new 2,800 sq ft Brandon, FL dispensary is now open for patients, with a...

1M ago

Fluent launches limited-edition Reindeer Reefer, Festivus Frost vape flavors

FLUENT announced the launch of two limited-edition holiday MOODS distillate vape flavors – Reindeer Reefer and Festivus Frost...

2M ago

FLUENT Corp. Reports Q2 2025 Earnings Amid Strategic Shift

Cansortium ( ($CNTMF) ) has released its Q2 earnings. Here is a breakdown of the information Cansortium presented...

4M ago

Fluent prices 3.5M shares at 6c in private placement financing

FLUENT Corp. intends to complete a non-brokered private placement offering of 3,500,000 common shares at a price of...

4M ago

Fluent reports Q2 EPS (2c) vs. 0c last year

Reports Q2 revenue $26.7M vs. $27.3M last year. “While Q2 results fell below expectations, just a few weeks...

4M ago

Fluent enters exclusive cultivation partnership with Connected

FLUENT announced the commencement of operations at its new 68,000+ square-foot indoor cultivation facility in Buffalo, New York....

4M ago

Fluent CEO Robert Beasley to resign, David Vautrin named interim

FLUENT announces that Robert Beasley has provided notice of his resignation from his positions as CEO and a...

5M ago

FLUENT Corp Reports Q1 2025 Financial Results

Cansortium ( ($CNTMF) ) has released its Q1 earnings. Here is a breakdown of the information Cansortium presented...

7M ago

Cansortium’s FLUENT debuts ‘New York Minute’ flavor for MOODS vaporizers

FLUENT Corp. is unveiling New York Minute, a bold new addition to its MOODS vaporizer portfolio. Flavored with...

8M ago

FLUENT launches KNACK multipack pre-rolls in New York

FLUENT is expanding its KNACK product line in New York with the launch of KNACK (Lit)les, a convenient...

8M ago

Cansortium’s Earnings Call: Record Revenue Amid Challenges

Cansortium (($TSE:FNT.U)) has held its Q4 earnings call. Read on for the main highlights of the call. Cansortium’s...

8M ago

CNTMF FAQ

What was Cansortium’s price range in the past 12 months?

Cansortium lowest stock price was $0.04 and its highest was $0.10 in the past 12 months.

What is Cansortium’s market cap?

Currently, no data Available

When is Cansortium’s upcoming earnings report date?

Cansortium’s upcoming earnings report date is May 04, 2026 which is in 128 days.

How were Cansortium’s earnings last quarter?

Cansortium released its earnings results on Nov 28, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.

Is Cansortium overvalued?

According to Wall Street analysts Cansortium’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cansortium pay dividends?

Cansortium does not currently pay dividends.

What is Cansortium’s EPS estimate?

Cansortium’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cansortium have?

Cansortium has 612,839,970 shares outstanding.

What happened to Cansortium’s price movement after its last earnings report?

Cansortium reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.

Which hedge fund is a major shareholder of Cansortium?

Currently, no hedge funds are holding shares in CNTMF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cansortium

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.